What inhaler regimen upgrade would you recommend for a 36-year-old woman with poorly controlled asthma who is currently using fluticasone/formoterol 100 µg/6 µg per actuation and salbutamol as needed?

Recommended Inhaler Upgrade

Increase to fluticasone/formoterol 250/10 mcg (or equivalent medium-dose ICS/LABA combination) twice daily, and switch from salbutamol to using the ICS/formoterol inhaler itself for as-needed symptom relief (maintenance and reliever therapy approach). This represents a step-up from your current low-dose ICS/LABA regimen and eliminates reliance on SABA-only rescue therapy.

Rationale for This Upgrade

Your current regimen of fluticasone/formoterol 100/6 mcg represents a low-dose ICS/LABA combination that is clearly insufficient given your poorly controlled asthma. The 2020 NAEPP guidelines 1 establish a stepwise approach where poorly controlled asthma on low-dose ICS/LABA (Step 3) requires escalation to medium-dose ICS/LABA (Step 4).

Why Medium-Dose ICS/LABA?

• Fluticasone/formoterol 250/10 mcg twice daily has demonstrated superior efficacy in moderate-to-severe asthma compared to individual components 2
• This dose achieved 25% improvement in FEV1 versus 15% with ICS alone in clinical trials 3
• Significantly fewer patients (3% vs 11-49%) were withdrawn due to worsening asthma on this regimen 3

Critical Change: Replace Salbutamol with ICS/Formoterol for Rescue

The most important modification is eliminating salbutamol as your rescue inhaler. The guidelines explicitly state that for Steps 3-4, the preferred quick-relief option is ICS-formoterol 1-2 puffs as needed 1. Here's why this matters:

• SABA overuse is dangerous: Real-world data shows that using just 3-5 salbutamol canisters per year associates with increased mortality risk, with substantially higher risk at 6-10 and ≥11 canisters annually 4
• ICS/formoterol as rescue reduces exacerbations: Studies demonstrate 54-90% reduction in severe exacerbations and hospitalizations when using ICS/formoterol for both maintenance and relief versus SABA-based regimens 5, 6, 7
• Lower steroid exposure paradoxically: Despite better control, maintenance-and-reliever therapy achieves this with less total ICS exposure than fixed-dose regimens 5

Specific Regimen

Maintenance: Fluticasone/formoterol 250/10 mcg, 1-2 inhalations twice daily

Rescue/Relief: Additional inhalations of the same fluticasone/formoterol inhaler as needed for symptoms (up to maximum total daily dose of 12 puffs/54 mcg formoterol) 1

Before Stepping Up: Essential Checks

The guidelines mandate assessing these factors before escalating therapy 1:

1. Inhaler technique - Most common cause of apparent treatment failure
2. Medication adherence - Are you actually taking it twice daily?
3. Environmental triggers - Allergen exposure, occupational exposures
4. Comorbid conditions - GERD, rhinosinusitis, obesity

If any of these are problematic, address them first. However, given you're on a genuinely low dose, stepping up is still appropriate.

When to Reassess

• Reassess control in 2-6 weeks after this step-up 1
• If well-controlled for at least 3 consecutive months, consider stepping down
• Consult an asthma specialist if you require Step 4 or higher therapy (which this represents) 1

Common Pitfalls to Avoid

1. Don't continue salbutamol as primary rescue - This perpetuates the cycle of poor control and increased mortality risk
2. Don't skip the maintenance doses - The reliever-only approach only works when combined with regular maintenance therapy
3. Monitor total daily formoterol dose - Maximum 12 puffs (54 mcg) total per day including maintenance and rescue 1
4. Watch for increasing rescue use - Using ICS/formoterol rescue >2 days/week still signals inadequate control and may require further step-up 1

Alternative if ICS/Formoterol Unavailable

If fluticasone/formoterol 250/10 mcg is not accessible, acceptable alternatives include:

• Budesonide/formoterol 160/4.5 mcg (2 inhalations twice daily, plus as-needed) - extensively studied for maintenance-and-reliever therapy 8, 5, 6
• Fluticasone propionate/salmeterol 250/50 mcg twice daily - though this requires separate SABA rescue and shows higher exacerbation rates than formoterol-based maintenance-and-reliever regimens 8, 5

The formoterol-containing combinations are strongly preferred because only formoterol has the rapid onset needed for effective rescue therapy while providing anti-inflammatory coverage with each rescue dose 1.